Japanese biopharmaceutical company Anaeropharma Science has received a $13.1 million investment from Seventure Partners, Europe’s leading venture capital firm focused on the microbiome space, according to an announcement on Wednesday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
